FDA Announces Major Steps to Implement Real-Time Clinical Trials
WHY IT MATTERS
Real-time clinical trials could speed up how quickly new treatments for rare diseases reach patients by allowing researchers to analyze data continuously rather than waiting months or years for traditional trial completion.
The FDA announced new steps to make clinical trials happen in real-time, meaning doctors can collect and use patient data as it happens instead of waiting until the end of a study. Real-time clinical trials could help researchers test new treatments faster and more efficiently. This is part of a bigger FDA effort to modernize how drug and treatment testing works.
The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT).